Advertisement Fidelity
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Will Truvada, as a prophylactic, have applications in

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
oc631 Member Profile
Member Level 
Followed By 11
Posts 1,560
Boards Moderated 0
Alias Born 08/12/07
160x600 placeholder
Long View On Stocks Is Best During Weak Earnings Season
Taking the long-term view is probably the best course of action for investors given the weakness of first-quarter results as we head into the peak week of first-quarter earnings season with reports from heavyweights like Apple Inc., Microsoft Corp., and AT&T Inc.
Client Balances at Morgan Stanley Wealth Management Near Merrill Lynch
Citi Picks Dewilde to Lead Asia Markets and Investor Services Business
U.S. Hot Stocks: Hot Stocks to Watch
IBM's Profit Slides As Hardware Sales Keep Falling
SanDisk, Weibo Gains Pace Tech Stocks
Fast-Rising Costs Erode Google's Profits -- 3rd Update
European Stocks Turn Higher, But Rémy, Diageo Lag
Yahoo CEO Mayer's Compensation Falls
FCC to Set Aside Spectrum for Smaller Wireless Carriers
oc631 Member Level  Saturday, 05/12/12 03:34:19 PM
Re: bladerunner1717 post# 141855
Post # of 177020 
Quote:
Will Truvada, as a prophylactic, have applications in the Third World, especially Africa? Wouldn't the Gates Foundation and WHO want to get involved with this drug?





Truvada prophylaxis testing was first done using prostitutes in Africa. Outside of cost there would be problems with user compliance in third world countries.

Prophylaxis seems like a good idea when demonstrated in a controlled environment, not in the third world. User compliance will be difficult even here in the U.S.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist